BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17325351)

  • 1. Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles.
    Ryding J; Dahlberg L; Wallen-Öhman M; Dillner J
    J Gen Virol; 2007 Mar; 88(Pt 3):792-802. PubMed ID: 17325351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Human Papillomavirus 16 L1+E2 Chimeric Capsomers Elicits Cellular Immune Response and Antitumor Activity in a Mouse Model.
    López-Toledo G; Schädlich L; Alonso-Castro ÁJ; Monroy-García A; García-Rocha R; Guido MC; Gissmann L; García-Carrancá A
    Viral Immunol; 2016 Jun; 29(5):276-87. PubMed ID: 27058179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity.
    Zhao Q; Modis Y; High K; Towne V; Meng Y; Wang Y; Alexandroff J; Brown M; Carragher B; Potter CS; Abraham D; Wohlpart D; Kosinski M; Washabaugh MW; Sitrin RD
    Virol J; 2012 Feb; 9():52. PubMed ID: 22356831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes.
    Thönes N; Müller M
    Virology; 2007 Dec; 369(2):375-88. PubMed ID: 17822733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5.
    Xia L; Xian Y; Wang D; Chen Y; Huang X; Bi X; Yu H; Fu Z; Liu X; Li S; An Z; Luo W; Zhao Q; Xia N
    Sci Rep; 2016 Jan; 6():19042. PubMed ID: 26750243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.
    Carpentier GS; Fleury MJ; Touzé A; Sadeyen JR; Tourne S; Sizaret PY; Coursaget P
    J Med Virol; 2005 Dec; 77(4):558-65. PubMed ID: 16254978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy.
    Guan J; Bywaters SM; Brendle SA; Lee H; Ashley RE; Christensen ND; Hafenstein S
    J Virol; 2015 Dec; 89(23):12108-17. PubMed ID: 26401038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a non-denaturing electrophoresis system for characterization of neutralizing epitopes on HPV virus-like particles.
    Studentsov YY; Burk RD
    J Virol Methods; 2007 Feb; 139(2):208-19. PubMed ID: 17137641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1.
    Carter JJ; Wipf GC; Benki SF; Christensen ND; Galloway DA
    J Virol; 2003 Nov; 77(21):11625-32. PubMed ID: 14557648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
    Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
    Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
    Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
    J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of multimeric human papillomavirus L2 vaccines.
    Jagu S; Kwak K; Karanam B; Huh WK; Damotharan V; Chivukula SV; Roden RB
    PLoS One; 2013; 8(1):e55538. PubMed ID: 23383218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A deletion and point mutation study of the human papillomavirus type 16 major capsid gene.
    Varsani A; Williamson AL; Jaffer MA; Rybicki EP
    Virus Res; 2006 Dec; 122(1-2):154-63. PubMed ID: 16938363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.
    Guan J; Bywaters SM; Brendle SA; Ashley RE; Makhov AM; Conway JF; Christensen ND; Hafenstein S
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29211035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a major neutralizing epitope on human papillomavirus type 16 L1.
    White WI; Wilson SD; Palmer-Hill FJ; Woods RM; Ghim SJ; Hewitt LA; Goldman DM; Burke SJ; Jenson AB; Koenig S; Suzich JA
    J Virol; 1999 Jun; 73(6):4882-9. PubMed ID: 10233949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment.
    Lee H; Brendle SA; Bywaters SM; Guan J; Ashley RE; Yoder JD; Makhov AM; Conway JF; Christensen ND; Hafenstein S
    J Virol; 2015 Jan; 89(2):1428-38. PubMed ID: 25392224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of HPV 16 L1/E7 DNA immunization: influence of cellular localization and capsid assembly.
    Kuck D; Leder C; Kern A; Müller M; Piuko K; Gissmann L; Kleinschmidt JA
    Vaccine; 2006 Apr; 24(15):2952-65. PubMed ID: 16414157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.
    Culp TD; Spatz CM; Reed CA; Christensen ND
    Virology; 2007 May; 361(2):435-46. PubMed ID: 17222883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera.
    Carter JJ; Wipf GC; Madeleine MM; Schwartz SM; Koutsky LA; Galloway DA
    J Virol; 2006 May; 80(10):4664-72. PubMed ID: 16641259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.